Melissa L Abel

7PUBLICATIONS
78CO-AUTHORS
Predictive and prognostic markersRadiation therapyMolecular targetsCardiology (incl. cardiovascular diseases)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 14, 2026
Intermittent enzalutamide in recurrent prostate cancer: testosterone kinetics and related toxicity.

|Jan 16, 2026
Molecular decoupling of lineage identity and morphology in aggressive variant prostate cancer.

Chennan Li, JuanJuan Yin, Melissa L Abel

|Oct 23, 2025
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations.

David J Einstein, Melissa L Abel, Jeanny B Aragon-Ching

|May 25, 2023
Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial.

Melissa L Abel, Nobuyuki Takahashi, Cody Peer

|Mar 29, 2023
The Potential Revolution of Cancer Treatment with CRISPR Technology.

Dimitrios Stefanoudakis, Nikhita Kathuria-Prakash, Alexander W Sun

|Dec 16, 2021
Inequity in Cardio-Oncology: Identifying Disparities in Cardiotoxicity and Links to Cardiac and Cancer Outcomes.

Rachel E Ohman, Eric H Yang, Melissa L Abel

Pageof 2

Frequent Collaborators

4 joint publications

William Douglas Figg

2 joint publications

Marijo Bilusic

2 joint publications

Ravi A Madan

2 joint publications

James L Gulley